OBIO CIK: 1814114

Orchestra BioMed Holdings, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−0.27
FY22:
−29.3
FY23:
−46.1
FY24:
−50.6
FY25:
−49.0
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−64.1
FY23:
10.7
FY24:
13.1
FY25:
−26.9
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
103
FY23:
46.2
FY24:
29.2
FY25:
88.3
millions USD
FY21:
−0.27
FY22:
9.85
FY23:
10.8
FY24:
−8.30
FY25:
12.4
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−29.9
FY23:
−46.2
FY24:
−50.8
FY25:
−49.5

All amounts in millions USD Data source:SEC EDGAR